PDT PHOTOSENSITIVITY
THE COMPLETE PROTECTION GUIDE

Photosensitivity after PDT is a direct consequence of residual photosensitiser remaining in skin tissue. After the treatment is delivered, the drug has not been fully cleared from the body — it remains in skin cells for days to weeks, depending on the agent. Any light exposure during this period activates the residual drug and generates reactive oxygen species in the skin.

“The key misunderstanding: PDT photosensitivity is triggered by VISIBLE light, not UV light. Sunscreen blocks UV. It does not block visible light. Wearing sunscreen after Photofrin PDT and going outside in sunlight will cause serious skin burns.”

• Visible Light, Not UV — The Critical Distinction

  Standard UV-blocking sunscreens provide NO protection against PDT phototoxic reactions. Photofrin absorbs light at 630 nm (red visible light) and at other visible wavelengths. These wavelengths are not blocked by UV filters in sunscreen. Protective clothing, staying out of sunlight, and managing indoor lighting are the only effective strategies during the Photofrin photosensitivity period.

• How Long the Risk Lasts

  Duration depends entirely on the photosensitiser used. Photofrin has a very long tissue half-life (~250 hours) and persists in skin for 4–6 weeks. Temoporfin (Foscan): 2–4 weeks. ALA/MAL skin PDT: 24–48 hours (treated skin area only — not the whole body). Verteporfin (ophthalmology): 5 days. Patients should receive specific written instructions from their treating team.

Photosensitivity requirements differ significantly between PDT agents. Know which agent you received.

Photofrin produces the most demanding and longest photosensitivity precautions. This section provides the detailed practical guidance needed for the full 4–6 week period.

• Outdoor Rules: Sunlight Avoidance

  Do not go outdoors in daylight without full protection: long-sleeved clothing, long trousers, gloves, hat with wide brim, and wraparound UV-blocking sunglasses (that also block visible light — standard UV sunglasses are insufficient; use category 4 filter lenses). Do not drive in direct sunlight without window film or dark covering on side windows. Dusk and dawn are lower risk; bright midday sun is highest risk.

• Indoor Rules: Bright Light Sources

  Bright indoor lighting CAN trigger phototoxic reactions in the first 2–4 weeks. Avoid: standing directly under unshielded bright fluorescent tubes, hairdresser lamps, photography studio lighting, dental surgery lighting, and UV examination lamps. Close blinds and curtains in sunny rooms. Normal domestic indoor lighting at standard distances (>2 metres from lamps) is generally tolerable but should be tested cautiously.

• The Test Window Exposure Approach

  After 4 weeks, patients can carefully test their light tolerance: expose a small area of skin (e.g., inner wrist) to indirect sunlight for 10 minutes. If no redness or stinging develops, cautious gradual return to normal outdoor activity can begin. If a reaction occurs, return to full precautions for another 1–2 weeks before re-testing.

• Eye Protection

  The eyes are also photosensitised after Photofrin injection. Wear sunglasses whenever outdoors — and consider sunglasses with side-shield coverage for maximum protection. In bright sunny outdoor conditions in the first 2 weeks, protective goggles or wrap-around sunglasses are recommended. Avoid ophthalmology examination lights, dental examination lights, and operating theatre lights during this period.

• Skin Products: What Is and Is Not Helpful

  UV-blocking sunscreen (SPF 30+) does NOT protect against PDT phototoxicity triggered by visible light. Physical sunscreens (titanium dioxide, zinc oxide) provide some protection by reflecting visible light as well as UV. Emollient moisturisers protect the skin barrier and support healing — use liberally on exposed areas. Steroid creams can help manage mild phototoxic reactions if they occur.

Despite precautions, accidental light exposure can occur. The severity of the reaction depends on light intensity, duration of exposure, and how recently the injection was given. Knowing what to do reduces harm.

• Immediately: Remove the Light Source

  Move indoors immediately. Draw curtains. Turn off bright lights. Change into clothing covering all exposed skin. The reaction begins rapidly after light exposure — the sooner the light source is eliminated, the less severe the reaction.

• For Mild Reactions (Redness, Mild Swelling)

  Cool the affected area with cool water compresses — not ice (can cause additional injury). Apply a bland emollient moisturiser. Take paracetamol for discomfort. Monitor for progression. Most mild reactions resolve within 24–48 hours with conservative management.

• For Severe Reactions (Blistering, Marked Swelling)

  Seek medical review promptly. Blistering indicates a more significant phototoxic burn. Do not burst blisters — they protect against infection. Medical team may prescribe topical steroids for inflammation and prophylactic antibiotics if blisters break. Wound care as for a thermal burn.

For topical ALA and MAL used in skin PDT, photosensitivity is limited to the treated area only and resolves within 24–48 hours. The precautions are dramatically less demanding than Photofrin.

• Treated Area Only — 24 to 48 Hours

  Only the skin area where cream was applied is photosensitised. The rest of the body is unaffected and normal activity is fine. For the treated area: avoid direct sun and bright light for 24–48 hours. A physical sunscreen (zinc oxide) provides useful visible-light protection for the treated area during this window.

• After 48 Hours: Normal Activity

  After 48 hours, normal sunlight exposure is safe on the treated area. The treated skin will remain red and healing for another 1–2 weeks — use emollient cream and avoid harsh products. Long-term sun protection (SPF 30+) is recommended for the healed area as part of good skin cancer prevention, but phototoxicity risk has resolved.

Related PDT topics and resources.

Frequently Asked Questions

Common questions about PDT photosensitivity management.